Isotope Crisis Highlights Timeliness of SNM Meeting

June 12, 2009 - With the Chalk River* nuclear reactor in Laurentian Hills, Ontario, Canada, shutdown, a reactor that supplies one-third** of the nuclear isotopes to the world, it was very timely when Canadian Prime Minister Stephen Harper welcomed the SNM annual meeting to Toronto, Canada, emphasizing the importance of molecular imaging to the future practice of medicine.

While the reactor is down for an undetermined amount of time, patients in North America requiring nuclear medicine procedures for diagnosing cancer, and neurological and cardiovascular diseases will face serious delays in medical treatment. As such, the medical isotope crisis places unprecedented importance on the SNM Annual Meeting, which called a press conference to address the issue: “Current Developments in the Medical Isotope Crisis and Molecular Imaging Research Breakthroughs,” on Monday, June 15, 11:30 a.m. to 12:45 p.m., in room 810 of the convention center.

The panel of top molecular imaging researchers, in addition to SNM President Robert W. Atcher, Ph.D, M.B.A., President-Elect Michael M. Graham, M.D., Ph.D, Peter S. Conti, M.D., Ph.D, and Henry N. Wagner, Jr., M.D., Johns Hopkins University, will discuss the latest developments surrounding the international medical isotope crisis; and announce major molecular imaging breakthroughs in the detection and treatment of cancers, heart and brain diseases.

Imaging Technology News will be providing all of the breaking news from the 2009 SNM Annual Meeting on ITNonline.net.

* The Chalk River nuclear reactor in Laurentian Hills, Ontario, Canada, is managed by the Atomic Energy of Canada Limited (AECL), a Canadian federal Crown corporation, that is a nuclear technology and engineering company that designed and developed the CANDU nuclear power reactor.
** According to medical doctor Jean-Luc Urbain, president of the Canadian Association of Nuclear Medicine, the Chalk River reactor supplies about 60 percent of the medical isotopes in the world, and the countries that will be most affected by the shortage are Canada and the U.S.

Read the 2017 article "FDA Clears Path for First Domestic Supply of Tc-99m Isotope." 

For more information: www.snm.org

Related Content

Feature | Nuclear Imaging

The "Nuclear Medicine Market Size, Share & Trends Analysis Report by Product (Diagnostics (SPECT, PET)), Therapeutics ...

Time May 26, 2022
arrow
News | Proton Therapy

May 25, 2022 — B dot Medical Inc. and Research Center for Nuclear Physics, Osaka University (RCNP) have conducted a ...

Time May 25, 2022
arrow
News | Contrast Media

May 19 2022 — Recent disruptions in a pharmaceutical supply chain have impacted the global availability of GE Healthcare ...

Time May 19, 2022
arrow
News | Contrast Media

May 18, 2022 —According to ARRS’ American Journal of Roentgenology (AJR), to ensure that patients with emergent or life ...

Time May 18, 2022
arrow
News | Radiopharmaceuticals and Tracers

May 16, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time May 16, 2022
arrow
News | Contrast Media

May 13, 2022 — The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware ...

Time May 13, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 13, 2022 — Alzheimer’s disease is the most common form of dementia, one of the major causes of dependency and ...

Time May 13, 2022
arrow
News | Nuclear Imaging

May 9, 2022 — Novartis announced a temporary, voluntary suspension of production at its radioligand therapy production ...

Time May 09, 2022
arrow
News | Proton Therapy

May 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

Time May 05, 2022
arrow
News | Coronavirus (COVID-19)

May 4, 2022 — While the COVID-19 pandemic transitions through various phases, nuclear cardiology teams should maintain a ...

Time May 04, 2022
arrow
Subscribe Now